Cargando…
Comparison of dynamic changes in the peripheral CD8(+) T cells function and differentiation in ESCC patients treated with radiotherapy combined with anti-PD-1 antibody or concurrent chemoradiotherapy
OBJECTIVE: The systematic immune status of cancer patients undergoing immunotherapy is little known. We prospectively identified the function and differentiation traits of peripheral CD8(+) T cells based on our phase 1b clinical trial (NCT03222440) of radiotherapy combined with camrelizumab in patie...
Autores principales: | Wei, Hui, Li, Yanqi, Guo, Zhoubo, Ma, Xiaoxue, Li, Yang, Wei, Xiaoying, Han, Dong, Zhang, Tian, Chen, Xi, Yan, Cihui, Zhou, Jiahuan, Pang, Qingsong, Wang, Ping, Zhang, Wencheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720318/ https://www.ncbi.nlm.nih.gov/pubmed/36479110 http://dx.doi.org/10.3389/fimmu.2022.1060695 |
Ejemplares similares
-
Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade
por: Ma, Xiaoxue, et al.
Publicado: (2022) -
Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2022) -
Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade
por: Yan, Cihui, et al.
Publicado: (2022) -
A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
por: Li, Yang, et al.
Publicado: (2021) -
Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study
por: Wu, Xiaoyue, et al.
Publicado: (2022)